(Q33992651)

30 July 2017

1 reference

title

New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? (English)

1 reference

30 July 2017

pseudomyxoma peritonei

1 reference

Paul H Sugarbaker

1

1 reference

30 July 2017

1 January 2006

1 reference

Lancet Oncology Commission

30 July 2017

1 reference

30 July 2017

7

1 reference

30 July 2017

69-76

1 reference

30 July 2017

1

1 reference

Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Are there curative options to peritoneal carcinomatosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Mucinous carcinoma of the colon and rectum

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Intraperitoneal cancer dissemination: mechanisms of the patterns of spread

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Clinical presentation of the Pseudomyxoma peritonei syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

The management of primary adenocarcinoma of the vermiform appendix

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Peritonectomy procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

[Pseudomyxoma peritonei: new concept and new therapeutic approach]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970539-8

7 January 2021

10.1016/S1470-2045(05)70539-8

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

16389186